125 related articles for article (PubMed ID: 24584550)
1. Impact of acute hyperglycemia on myocardial infarct size, area at risk, and salvage in patients with STEMI and the association with exenatide treatment: results from a randomized study.
Lønborg J; Vejlstrup N; Kelbæk H; Nepper-Christensen L; Jørgensen E; Helqvist S; Holmvang L; Saunamäki K; Bøtker HE; Kim WY; Clemmensen P; Treiman M; Engstrøm T
Diabetes; 2014 Jul; 63(7):2474-85. PubMed ID: 24584550
[TBL] [Abstract][Full Text] [Related]
2. Cardioprotective effects of exenatide in patients with ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention: results of exenatide myocardial protection in revascularization study.
Woo JS; Kim W; Ha SJ; Kim JB; Kim SJ; Kim WS; Seon HJ; Kim KS
Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2252-60. PubMed ID: 23868944
[TBL] [Abstract][Full Text] [Related]
3. Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction.
Lønborg J; Vejlstrup N; Kelbæk H; Bøtker HE; Kim WY; Mathiasen AB; Jørgensen E; Helqvist S; Saunamäki K; Clemmensen P; Holmvang L; Thuesen L; Krusell LR; Jensen JS; Køber L; Treiman M; Holst JJ; Engstrøm T
Eur Heart J; 2012 Jun; 33(12):1491-9. PubMed ID: 21920963
[TBL] [Abstract][Full Text] [Related]
4. Exenatide reduces final infarct size in patients with ST-segment-elevation myocardial infarction and short-duration of ischemia.
Lønborg J; Kelbæk H; Vejlstrup N; Bøtker HE; Kim WY; Holmvang L; Jørgensen E; Helqvist S; Saunamäki K; Terkelsen CJ; Schoos MM; Køber L; Clemmensen P; Treiman M; Engstrøm T
Circ Cardiovasc Interv; 2012 Apr; 5(2):288-95. PubMed ID: 22496084
[TBL] [Abstract][Full Text] [Related]
5. Sex differences in myocardial salvage and clinical outcome in patients with acute reperfused ST-elevation myocardial infarction: advances in cardiovascular imaging.
Eitel I; Desch S; de Waha S; Fuernau G; Gutberlet M; Schuler G; Thiele H
Circ Cardiovasc Imaging; 2012 Jan; 5(1):119-26. PubMed ID: 22028459
[TBL] [Abstract][Full Text] [Related]
6. Impact of system delay on infarct size, myocardial salvage index, and left ventricular function in patients with ST-segment elevation myocardial infarction.
Lønborg J; Schoos MM; Kelbæk H; Holmvang L; Steinmetz J; Vejlstrup N; Jørgensen E; Helqvist S; Saunamäki K; Bøtker HE; Kim WY; Terkelsen CJ; Clemmensen P; Engstrøm T
Am Heart J; 2012 Oct; 164(4):538-46. PubMed ID: 23067912
[TBL] [Abstract][Full Text] [Related]
7. Intracoronary compared with intravenous bolus abciximab application during primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: cardiac magnetic resonance substudy of the AIDA STEMI trial.
Eitel I; Wöhrle J; Suenkel H; Meissner J; Kerber S; Lauer B; Pauschinger M; Birkemeyer R; Axthelm C; Zimmermann R; Neuhaus P; Brosteanu O; de Waha S; Desch S; Gutberlet M; Schuler G; Thiele H
J Am Coll Cardiol; 2013 Apr; 61(13):1447-54. PubMed ID: 23466078
[TBL] [Abstract][Full Text] [Related]
8. Intensive glucose regulation in hyperglycemic acute coronary syndrome: results of the randomized BIOMarker study to identify the acute risk of a coronary syndrome-2 (BIOMArCS-2) glucose trial.
de Mulder M; Umans VA; Cornel JH; van der Zant FM; Stam F; Oemrawsingh RM; Akkerhuis KM; Boersma E
JAMA Intern Med; 2013 Nov; 173(20):1896-904. PubMed ID: 24018647
[TBL] [Abstract][Full Text] [Related]
9. Osteoprotegerin in ST-elevation myocardial infarction: prognostic impact and association with markers of myocardial damage by magnetic resonance imaging.
Fuernau G; Zaehringer S; Eitel I; de Waha S; Droppa M; Desch S; Schuler G; Adams V; Thiele H
Int J Cardiol; 2013 Sep; 167(5):2134-9. PubMed ID: 22704876
[TBL] [Abstract][Full Text] [Related]
10. Hyperglycemia and adverse outcomes in acute coronary syndromes: is serum glucose the provocateur or innocent bystander?
Wei CH; Litwin SE
Diabetes; 2014 Jul; 63(7):2209-12. PubMed ID: 24962919
[No Abstract] [Full Text] [Related]
11. Prognostic impact of hyperglycemia in nondiabetic and diabetic patients with ST-elevation myocardial infarction: insights from contrast-enhanced magnetic resonance imaging.
Eitel I; Hintze S; de Waha S; Fuernau G; Lurz P; Desch S; Schuler G; Thiele H
Circ Cardiovasc Imaging; 2012 Nov; 5(6):708-18. PubMed ID: 23051889
[TBL] [Abstract][Full Text] [Related]
12. Exenatide reduces infarct size and improves cardiac function in a porcine model of ischemia and reperfusion injury.
Timmers L; Henriques JP; de Kleijn DP; Devries JH; Kemperman H; Steendijk P; Verlaan CW; Kerver M; Piek JJ; Doevendans PA; Pasterkamp G; Hoefer IE
J Am Coll Cardiol; 2009 Feb; 53(6):501-10. PubMed ID: 19195607
[TBL] [Abstract][Full Text] [Related]
13. No benefit of additional treatment with exenatide in patients with an acute myocardial infarction.
Roos ST; Timmers L; Biesbroek PS; Nijveldt R; Kamp O; van Rossum AC; van Hout GP; Stella PR; Doevendans PA; Knaapen P; Velthuis BK; van Royen N; Voskuil M; Nap A; Appelman Y
Int J Cardiol; 2016 Oct; 220():809-14. PubMed ID: 27394978
[TBL] [Abstract][Full Text] [Related]
14. Glucose normalization and outcomes in patients with acute myocardial infarction.
Kosiborod M; Inzucchi SE; Krumholz HM; Masoudi FA; Goyal A; Xiao L; Jones PG; Fiske S; Spertus JA
Arch Intern Med; 2009 Mar; 169(5):438-46. PubMed ID: 19273773
[TBL] [Abstract][Full Text] [Related]
15. Impact of primary coronary angioplasty delay on myocardial salvage, infarct size, and microvascular damage in patients with ST-segment elevation myocardial infarction: insight from cardiovascular magnetic resonance.
Francone M; Bucciarelli-Ducci C; Carbone I; Canali E; Scardala R; Calabrese FA; Sardella G; Mancone M; Catalano C; Fedele F; Passariello R; Bogaert J; Agati L
J Am Coll Cardiol; 2009 Dec; 54(23):2145-53. PubMed ID: 19942086
[TBL] [Abstract][Full Text] [Related]
16. Effect of exenatide on 24-hour blood glucose profile compared with placebo in patients with type 2 diabetes: a randomized, double-blind, two-arm, parallel-group, placebo-controlled, 2-week study.
Schwartz SL; Ratner RE; Kim DD; Qu Y; Fechner LL; Lenox SM; Holcombe JH
Clin Ther; 2008 May; 30(5):858-67. PubMed ID: 18555933
[TBL] [Abstract][Full Text] [Related]
17. A high loading dose of clopidogrel reduces myocardial infarct size in patients undergoing primary percutaneous coronary intervention: a magnetic resonance imaging study.
Song YB; Hahn JY; Gwon HC; Chang SA; Lee SC; Choe YH; Choi SH; Choi JH; Lee SH; Oh JK
Am Heart J; 2012 Mar; 163(3):500-7. PubMed ID: 22424023
[TBL] [Abstract][Full Text] [Related]
18. Prediction of enzymatic infarct size in ST-segment elevation myocardial infarction.
Mills JS; Mahaffey KW; Lokhnygina Y; Nicolau JC; Ruzyllo W; Adams PX; Todaro TG; Armstrong PW; Granger CB;
Coron Artery Dis; 2012 Mar; 23(2):118-25. PubMed ID: 22217457
[TBL] [Abstract][Full Text] [Related]
19. Acute hyperglycaemia and inflammation in patients with ST segment elevation myocardial infarction.
Terlecki M; Bednarek A; Kawecka-Jaszcz K; Czarnecka D; Bryniarski L
Kardiol Pol; 2013; 71(3):260-7. PubMed ID: 23575781
[TBL] [Abstract][Full Text] [Related]
20. Post-conditioning reduces infarct size and edema in patients with ST-segment elevation myocardial infarction.
Thuny F; Lairez O; Roubille F; Mewton N; Rioufol G; Sportouch C; Sanchez I; Bergerot C; Thibault H; Cung TT; Finet G; Argaud L; Revel D; Derumeaux G; Bonnefoy-Cudraz E; Elbaz M; Piot C; Ovize M; Croisille P
J Am Coll Cardiol; 2012 Jun; 59(24):2175-81. PubMed ID: 22676937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
